Skip to content
20-F

Annual Report (Foreign)

XYRATEX LTD

0001047469-13-001397

← back to feed
Filed
Feb 21, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Nov 30, 2012 27.02M sh
Current Liabilities FY 2012 · Nov 30, 2011 $224.53M
Total Liabilities FY 2012 · Nov 30, 2011 $224.53M
Current Assets FY 2012 · Nov 30, 2011 $516.88M
Total Assets FY 2012 · Nov 30, 2011 $593.7M
Shares Diluted FY 2012 · Nov 30, 2010 31.27M sh
Capex FY 2012 · Nov 30, 2010 $20.33M
Eps Diluted FY 2012 · Nov 30, 2010 $4.46
Eps Basic FY 2012 · Nov 30, 2010 $4.63
Sga Expense FY 2012 · Nov 30, 2010 $60M
Rd Expense FY 2012 · Nov 30, 2010 $92.71M
Operating Income FY 2012 · Nov 30, 2010 $123.39M
Gross Profit FY 2012 · Nov 30, 2010 $279.77M
Cost Of Revenue FY 2012 · Nov 30, 2010 $1.32B
Cash And Equivalents FY 2012 · Nov 30, 2009 $51.94M
Stockholders Equity FY 2012 · Nov 30, 2009 $219.24M